ID: h-f8b19743a2
Hypothesis
Moderate hyperoxia (1.5-2.0 ATA) optimally stabilizes HIF-1α to enhance VEGF-mediated angiogenesis and cerebral perfusion in AD
This hypothesis claims HBOT at 1.5-2.0 ATA produces sub-lethal oxidative stress that paradoxically stabilizes HIF-1α despite increasing oxygen tension, driving VEGF transcription and restoring cerebral perfusion.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
This hypothesis claims HBOT at 1.5-2.0 ATA produces sub-lethal oxidative stress that paradoxically stabilizes HIF-1α despite increasing oxygen tension, driving VEGF transcription and restoring cerebral perfusion. The mechanistic foundation is contested: hyperoxia typically promotes HIF degradation via PHD enzymes. Additionally, VEGF-driven angiogenesis in AD is double-edged and may worsen BBB leakiness if new vessels are immature.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["HBOT 1.5-2.0 ATA<br/>Moderate Hyperoxia"]
B["Sub-lethal ROS Generation<br/>Oxidative eustress"]
C["PHD Enzyme Paradoxical<br/>Activity Reduction"]
D["HIF-1alpha Stabilization<br/>Despite elevated oxygen"]
E["VEGF Transcription<br/>HRE-driven gene expression"]
F["Angiogenesis<br/>New vessel formation"]
G["Cerebral Perfusion<br/>Restoration"]
H["Cognitive Improvement<br/>AD patients"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> G
G --> H
style A fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7
style D fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style H fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7⚖️ Evidence
⚖️ Evidence Matrix3 supports3 contradicts
Contradicts
HIF-1α and VEGF elevated in stressed AD tissue can reflect pathology rather than repair
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — HIF1A
No curated PDB or AlphaFold mapping for HIF1A yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for HIF1A from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for HIF1A.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0156
Events (7d)
1
Price History
▲3.4%💾 Resource Usage
LLM Tokens
11,804
$0.0354
Total Cost
$0.0354
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF aged APP/PS1 mice receive 40 sessions of HBOT at 1.8 ATA THEN cerebral perfusion (measured by arterial spin labeling MRI) will increase by ≥25% AND serum claudin-5 (BBB integrity marker) will not d | CBF increase ≥25% in hippocampus (from ~45 to ≥56 mL/100g/min) with claudin-5 serum levels remaining within 15% of baseline (normoxia: ~8.5 ng/mL) | — no observation — | pending | 0.38 |
| IF aged APP/PS1 mice receive 20 sessions of HBOT at 1.8 ATA (90 min/session, 5 days/week) THEN brain HIF-1α protein levels will increase by ≥40% relative to normoxic controls, as measured by ELISA of | HIF-1α protein concentration in hippocampus will increase from baseline (normoxia: ~0.8 ng/mg protein) to ≥1.12 ng/mg protein in HBOT group | — no observation — | pending | 0.45 |
🔮 Falsifiable Predictions (2)
pendingconf 45%
IF aged APP/PS1 mice receive 20 sessions of HBOT at 1.8 ATA (90 min/session, 5 days/week) THEN brain HIF-1α protein levels will increase by ≥40% relative to normoxic controls, as measured by ELISA of hippocampal tissue collected within 2 hours of final session.
Predicted outcome: HIF-1α protein concentration in hippocampus will increase from baseline (normoxia: ~0.8 ng/mg protein) to ≥1.12 ng/mg protein in HBOT group
Falsification: HIF-1α protein levels do not increase (≤10% change) or decrease significantly (p>0.05 by unpaired t-test) in HBOT group versus controls
pendingconf 38%
IF aged APP/PS1 mice receive 40 sessions of HBOT at 1.8 ATA THEN cerebral perfusion (measured by arterial spin labeling MRI) will increase by ≥25% AND serum claudin-5 (BBB integrity marker) will not decrease below baseline, compared to sham controls, at 8 weeks post-intervention.
Predicted outcome: CBF increase ≥25% in hippocampus (from ~45 to ≥56 mL/100g/min) with claudin-5 serum levels remaining within 15% of baseline (normoxia: ~8.5 ng/mL)
Falsification: Either cerebral perfusion fails to increase ≥25% (insufficient angiogenesis) OR claudin-5 serum levels decrease >25% (indicating BBB disruption), with either outcome indicating the VEGF-driven angioge
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.